- Perera V, Gross AS, Xu H, McLachlan AJ: Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics. J Pharm Pharmacol. 2011 Sep;63(9):1161-8. doi: 10.1111/j.2042-7158.2011.01326.x. Epub 2011 Jul 6. [PubMed:21827488 ]
- Grant DM, Tang BK, Kalow W: Variability in caffeine metabolism. Clin Pharmacol Ther. 1983 May;33(5):591-602. doi: 10.1038/clpt.1983.80. [PubMed:6687705 ]
- Carrillo JA, Benitez J: Caffeine metabolism in a healthy Spanish population: N-acetylator phenotype and oxidation pathways. Clin Pharmacol Ther. 1994 Mar;55(3):293-304. doi: 10.1038/clpt.1994.30. [PubMed:8143395 ]
- Jeppesen U, Loft S, Poulsen HE, Brsen K: A fluvoxamine-caffeine interaction study. Pharmacogenetics. 1996 Jun;6(3):213-22. doi: 10.1097/00008571-199606000-00003. [PubMed:8807660 ]
- Cysneiros RM, Farkas D, Harmatz JS, von Moltke LL, Greenblatt DJ: Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Clin Pharmacol Ther. 2007 Jul;82(1):54-62. doi: 10.1038/sj.clpt.6100211. Epub 2007 Apr 18. [PubMed:17443132 ]
- Amchin J, Zarycranski W, Taylor KP, Albano D, Klockowski PM: Effect of venlafaxine on CYP1A2-dependent pharmacokinetics and metabolism of caffeine. J Clin Pharmacol. 1999 Mar;39(3):252-9. [PubMed:10073324 ]
- Bonati M, Latini R, Galletti F, Young JF, Tognoni G, Garattini S: Caffeine disposition after oral doses. Clin Pharmacol Ther. 1982 Jul;32(1):98-106. doi: 10.1038/clpt.1982.132. [PubMed:7083737 ]
- Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, Shader RI: Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. J Clin Pharmacol. 1997 Aug;37(8):693-703. doi: 10.1002/j.1552-4604.1997.tb04356.x. [PubMed:9378841 ]
- Xiao J, Huang WH, Peng JB, Tan ZR, Ou-Yang DS, Hu DL, Zhang W, Chen Y: Quercetin significantly inhibits the metabolism of caffeine, a substrate of cytochrome P450 1A2 unrelated to CYP1A2*1C (-2964G>A) and *1F (734C>A) gene polymorphisms. Biomed Res Int. 2014;2014:405071. doi: 10.1155/2014/405071. Epub 2014 Jun 15. [PubMed:25025048 ]
- Rodopoulos N, Norman A: Assessment of dimethylxanthine formation from caffeine in healthy adults: comparison between plasma and saliva concentrations and urinary excretion of metabolites. Scand J Clin Lab Invest. 1996 May;56(3):259-68. doi: 10.3109/00365519609088615. [PubMed:8761530 ]
- Blanchard J, Sawers SJ, Jonkman JH, Tang-Liu DD: Comparison of the urinary metabolite profile of caffeine in young and elderly males. Br J Clin Pharmacol. 1985 Feb;19(2):225-32. doi: 10.1111/j.1365-2125.1985.tb02635.x. [PubMed:3986081 ]